PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Dental Medicine Department, AP-HP, Mondor Hospital, Créteil, France.\', \'Inserm UMR S 1145, Institut Droit et Santé, Université de Paris, Paris, France.\', \'Dental Medicine Department, AP-HP, Bretonneau Hospital, Paris, France.\', \'Université de Paris, Laboratory of Orofacial Neurobiology (EA 7543), Paris, France.\', \'Dental Innovation and Translation Hub, Faculty of Dentistry, Oral & Craniofacial Sciences, Kings College London, Guy\'s Hospital, London, United Kingdom.\', \'Université de Paris, Laboratory of Orofacial Pathologies, Imaging and Biotherapies, Montrouge, France.\', \'Université de Paris, EA 7323 Pharmacologie Et Thérapeutique de L\'enfant Et de La Femme Enceinte, Paris, France.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.pone.0261439
?:doi
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 34936675
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
is ?:relation_isRelatedTo_publication of
?:title
  • Application of recommended preventive measures against COVID-19 could help mitigate the risk of SARS-CoV-2 infection during dental practice: Results from a follow-up survey of French dentists.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all